Home / Market News / $MEDP
fiscal.ai Corporate Catalyst Impact 65/100 ● neutral

Analysts Update Price Targets and Ratings for Medpace Holdings, Inc.

Oct 25, 2026, 1:03 AM UTC · Primary ticker $MEDP

Multiple analysts have updated their price targets for Medpace Holdings, Inc., with all three raising their targets while maintaining existing ratings. This indicates a positive sentiment regarding the company's growth prospects and current market position, suggesting potential upward pressure on the stock.

This 8-K filing discloses that UBS, Barclays, and TD Cowen have all raised their price targets for Medpace Holdings, Inc. (MEDP). UBS cited strong order bookings and a robust project pipeline as reasons for their increase. While ratings remained neutral or hold, the significant upward adjustments in price targets, particularly TD Cowen's substantial raise, signal increased confidence in MEDP's future performance and valuation. This is a positive development for MEDP, potentially attracting more investor interest and supporting its stock price in the short to medium term, as it reflects a more optimistic outlook from key institutional analysts.

$MEDP positive Analyst price target increases
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.